false

Chad Clark

Recognized industry leader with deep expertise spanning biomarker-driven clinical development, patient access and global market access. In addition to the role at Precision Medicine Group, Chad is also President of Precision for Medicine. In prior roles he has served as Chief Operating Officer of United BioSource Corporation and founder of DataPhaseIV. Proven ability to scale operations in response to client needs, adding the end-to-end capabilities necessary to support development and patient access to today’s complex therapies.

• Read: Challenges & Opportunities in Cell and Gene Therapy

  Manufacturing

  Challenges & Opportunities in Cell and Gene Therapy

  Oct 15, ‘24 | 1 min read

  • 

    Anshul Mangal

  Discover
• Read: How European Oncology Site Networks Streamline Clinical Trial Site Selection

  Clinical Trials - Oncology

  How European Oncology Site Networks Streamline Clinical Trial Site Selection

  Oct 14, ‘24 | 6 min read

  • 

    Deana Demjen

  Discover
• Read: Clinical Trial Trends: Early Phase Oncology

  Clinical Trials - Early Phase Research - Oncology

  Clinical Trial Trends: Early Phase Oncology

  Oct 12, ‘24 | 4 min read

  • 

    Natacha Grand

  Discover
• Read: The Dose Dilemma: Lessons from Sotorasib and the Future of Oncology Drug Optimization

  Clinical Trials - Oncology

  The Dose Dilemma: Lessons from Sotorasib and the Future of Oncology Drug Optimization

  Oct 11, ‘24 | 6 min read

  • 

    Harpreet Singh, MD

  Discover
• Read: Why Antibody-Drug Conjugates Are Revolutionizing Precision Oncology

  Clinical Trials - Oncology

  Why Antibody-Drug Conjugates Are Revolutionizing Precision Oncology

  Oct 11, ‘24 | 9 min read

  • 

    Ivan Barrera

  Discover
• Read: Therapeutic Genome Editing – Reshaping the Landscape of Advanced Therapies

  Regulatory - Gene Therapies

  Therapeutic Genome Editing – Reshaping the Landscape of Advanced Therapies

  Oct 10, ‘24 | 2 min read

  • 

    Precision Experts

  Discover
• Read: Clinical Trial Trends: Non-Hodgkin’s Lymphoma

  Clinical Trials - Oncology

  Clinical Trial Trends: Non-Hodgkin’s Lymphoma

  Sep 24, ‘24 | 6 min read

  • 

    Jen Vance

  Discover
• Read: US Crackdown on Chinese Clinical Trials: What’s at Stake for Biopharma?

  Manufacturing

  US Crackdown on Chinese Clinical Trials: What’s at Stake for Biopharma?

  Sep 18, ‘24 | 1 min read

  • 

    Anshul Mangal

  Discover
• Read: Safety isn’t a Milestone but a Mindset in Clinical Research

  Clinical Trials

  Safety isn’t a Milestone but a Mindset in Clinical Research

  Sep 16, ‘24 | 6 min read

  • 

    Renise Blythe

  Discover

Loading...

You've reach the end Back to top